Comment on: F. M. Scherer, "How US antitrust can go astray: the brand name prescription drug litigation"
Year of publication: |
1997
|
---|---|
Authors: | Zaretsky, Henry W. |
Published in: |
International journal of the economics of business. - Abingdon, Oxfordshire : Routledge, ISSN 1357-1516, ZDB-ID 1196953-2. - Vol. 4.1997, 3, p. 271-275
|
Subject: | USA | United States | Theorie | Theory | Wettbewerbspolitik | Competition policy | Pharmaindustrie | Pharmaceutical industry | Pharmahandel | Pharmaceutical distributors |
-
How US antitrust can go astray : the brand name prescription drug litigation
Scherer, Frederic M., (2000)
-
How US antitrust can go astray : the brand name prescription drug litigation
Scherer, Frederic M., (1997)
-
Zweifel, Peter, (1997)
- More ...
-
The effects of patient mix and service mix on hospital costs and productivity
Zaretsky, Henry W., (1982)
-
Zaretsky, Henry W., (1997)
- More ...